Latest Articles

Publication Date
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive

Published: Feb. 5, 2025, 5:17 p.m.
The Link Between Cancer and Endometriosis You Need to Know About - Well+Good

The Link Between Cancer and Endometriosis You Need to Know About Well+Good

Published: Feb. 5, 2025, 3:33 p.m.
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting - Cureus

A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting Cureus

Published: Feb. 5, 2025, 1:26 p.m.
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.
Acrivon's AI-Powered Cancer Test Achieves 62.5% Response Rate, Earns FDA Breakthrough Status - StockTitan

Acrivon's AI-Powered Cancer Test Achieves 62.5% Response Rate, Earns FDA Breakthrough Status StockTitan

Published: Feb. 5, 2025, 1 p.m.
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com

Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com

Published: Feb. 5, 2025, 11:37 a.m.
Unraveling the role of lncRNA in Endometriosis-Associated immune system Dysregulation: Exploring the intricate immunological changes and disrupted signaling pathways.

A chronic illness known as endometriosis impacts women who are of reproductive maturity. It may be a factor in fertility problems, breast or ovarian cancer, asthma, cardiovascular illness, or pelvic …

Published: Feb. 5, 2025, midnight
Cancer risk could increase by hot water bottle use, doctor warns - Gloucestershire Live

Cancer risk could increase by hot water bottle use, doctor warns Gloucestershire Live

Published: Feb. 4, 2025, 1:40 p.m.
Doctor issues urgent cancer warning over hot water bottles - don't do this - The Mirror

Doctor issues urgent cancer warning over hot water bottles - don't do this The Mirror

Published: Feb. 4, 2025, 1:31 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!